Led · Series B · Aug 2026

ShipIn provides an AI-driven operational intelligence platform for commercial shipping, converting onboard vessel data into actionable insights to improve safety, productivity, and performance. Its platform is deployed by over 90 shipowners across more than 1,300 vessels. The company raised $52 million to expand its AI platform and accelerate growth as the industry adopts more data-driven operations. Investors in the round include Proofpoint Capital, HighSage Ventures, Bling Capital, Framework Venture Partners, Tokio Marine HCC's Future Fund, Zeev Ventures, Munich Re, Atinc, Hyperplane, and Two Lanterns Venture Capital. Two Lanterns has been an investor since ShipIn’s Seed round. The company is led by Osher Perry, who was highlighted in the announcement.

Participated · Series A · Jul 2026

Founded in 2021 and based in Texas, Klinic provides a unified digital infrastructure for independent specialty providers, initially focused on behavioral health and now expanded into oncology, cardiology and rare diseases. Its platform aggregates tools for patient acquisition, intake, electronic health records, customer relationship management, care coordination and revenue-cycle support. Klinic also runs services that connect specialty pharmaceutical manufacturers with providers and patients to support access to complex therapies. The company positions itself as a healthcare equivalent of Shopify for specialists, aiming to reduce administrative burdens such as prior authorizations and workflow management. Klinic plans to use newly raised capital to expand the platform across multiple specialties, while facing the challenge of scaling and competing with established EHR vendors and healthcare software companies.

Led · Series A · Dec 2025

Founded in 2021, Denver-based Lin Health offers a physician-led, coach-supported virtual program that retrains maladaptive pain circuits through therapies such as Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, and Cognitive Behavioral Therapy. The platform combines proprietary software, AI, and a collaborative care model to engage patients multiple times per week without adding administrative burden. Lin partners with health systems, clinics, and payers and is already accessible to more than 60 million covered Americans. Its solution targets chronic conditions including migraines, IBS, back pain, and joint pain, addressing a $635 billion annual cost burden in the U.S. healthcare system. The company emphasizes value-based outcomes, reduced provider burnout, and lower total cost of care. With fresh Series A capital, Lin plans to accelerate product innovation, scale go-to-market efforts, and deepen clinically integrated partnerships. The oversubscribed funding signals strong investor confidence in Lin’s ability to become the first-line solution for chronic pain nationwide.